| lurasidone / Generic mfg. |
2017-002406-12: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuation/dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis HAMLETT. Handling Antipsychotic Medication: Lange termijn evaluatie van specifiek toegepaste medicatie. Vergelijking tussen het doorgaan met antipsychotische medicatie bij patiënten die hersteld zijn van eerste psychotische episode en vroegtijdig afbouwen/stoppen. |
|
|
| Not yet recruiting | 4 | 512 | Europe | RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE, CID5073, CID135398745, CID5002, CID60795, CID3559, CID5355, CID115237, CID16362, CID213046, CID135398737, CID2159, CID5467, CID60149, CID667467, CIS5311507, Tablet, RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE | University Medical Center Groningen, ZonMw | HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation. HAMLETT vergelijkt de reguliere behandeling van patiënten in remissie na een eerste psychotische episode zoals beschreven in de richtlijnen, namelijk het continueren van antipsychotica voor minstens 1 jaar, met het vroegtijdig afbouwen/stoppen met medicatie., HAMLETT compares continuation versus early discontinuation of antipsychotic medication in patients who have recovered from their first episode of psychosis. HAMLETT vergelijkt de reguliere behandeling van patiënten die hersteld zijn van een eerste psychose, namelijk minimaal 1 jaar antipsychotica gebruiken, met vroegtijdig afbouwen/stoppn met medicatie, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2021-003816-20: Effect of lurasidone on cerebral structure in patients with recent-onset schizophrenia Impatto della terapia antipsicotica con lurasidone sulla struttura cerebrale dei pazienti con schizofrenia ad esordio recente |
|
|
| Not yet recruiting | 4 | 20 | Europe | Latuda, [Lurasidone], Film-coated tablet, LATUDA - 37 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER ALU/ALU - 28X1 COMPRESSE (DOSE UNITARIA), LATUDA - 18,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER ALU/ALU - 1X28 COMPRESSE (DOSE UNITARIA), LATUDA - 74 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER ALU/ALU - 28X1 COMPRESSE (DOSE UNITARIA) | FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, Società Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. - Viale Amelia, 70 - Roma | Schizophrenia Schizofrenia, Schizophrenia Schizofrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
DSPCLAT-003, NCT05011669: The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia |
|
|
| Completed | 4 | 200 | RoW | Lurasidone | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 04/23 | 06/23 | | |
NCT05213143: The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine |
|
|
| Terminated | 4 | 13 | RoW | Lurasidone | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 11/22 | 11/22 | | |
ChiCTR2100049426: A randomized and controlled study of ruracidone in the treatment of bipolar depression in adolescents and early adulthood |
|
|
| Not yet recruiting | 4 | 60 | | treatment with lurasidone ;treatment with quetiapine | Beijing AnDing Hospital, Capital Medical University; Beijing AnDing Hospital, Capital Medical University, Beijing Hospital Authority | bipolar disorder | | | | |
| Recruiting | 4 | 10 | Europe | Lurasidone | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Società Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. - Viale Amelia, 70 - Roma | Schizophrenia | 01/24 | 04/24 | | |
| Not yet recruiting | 4 | 2726 | Canada, US | Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda | Massachusetts General Hospital, Patient-Centered Outcomes Research Institute | Bipolar I Disorder, Depression | 02/30 | 02/30 | | |
NCT05741502: An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine |
|
|
| Recruiting | 4 | 60 | US | Clozapine, Antipsychotics,Other (non-Clozapine), Including Olanzapine, Risperidone, Paliperidone, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, and all Typical antipsychotics | Ohio State University | Treatment-resistant Schizophrenia | 03/26 | 06/26 | | |
2016-000061-23: A 12-Week Extension Study looking at the effects of Lurasidone (SM-13496) in Subjects with Schizophrenia |
|
|
| Ongoing | 3 | 283 | Europe | Lurasidone, SM-13496, Film-coated tablet, Latuda | Sunovion Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc. | Schizophrenia, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2019-002213-19: A randomised study to evaluate Lurasidone versus Placebo in improving cognitive functioning in patients with Bipolar Disorder |
|
|
| Ongoing | 3 | 300 | Europe | Latuda, n/a, Film-coated tablet, Latuda | University of British Columbia, University of British Columbia | Euthymic Bipolar disorder, Bipolar Disorder, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT03465787: A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia |
|
|
| Completed | 3 | 210 | RoW | Lurasidone HCL 160 mg, Quetiapine XR 600 mg | Bukwang Pharmaceutical | Schizophrenia | 10/22 | 10/22 | | |
SBD-ASIB, NCT03396068: NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation |
|
|
| Active, not recruiting | 3 | 72 | US | NRX-101, Cyclurad, Lurasidone HCl | NeuroRx, Inc., Target Health Inc. | Bipolar Depression, Suicidal Ideation | 12/24 | 12/24 | | |
|
| Completed | 3 | 100 | Europe, Canada, Japan, US | lurasidone, Latuda, Placebo | Lakshmi N Yatham | Bipolar Disorder | 12/24 | 12/24 | | |
| Completed | 2/3 | 74 | US | NRX-101, Lurasidone HCl, Latuda | NeuroRx, Inc., Prevail Infoworks, Inc | Bipolar Depression, Suicidal Ideation and Behavior | 02/24 | 03/24 | | |
NCT06128213: NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis |
|
|
| Not yet recruiting | 2 | 13 | NA | NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone)) | NeuroRx, Inc. | Urinary Tract Infections, Pyelonephritis | 06/24 | 09/24 | | |
| Completed | N/A | 61 | Europe | Lurasidone | Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research | Schizophrenia | 09/23 | 09/23 | | |
SWITCH, NCT04312503: Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" |
|
|
| Completed | N/A | 95 | Europe | Lurasidone, Latuda, aripiprazole, olanzapine, quetiapine or risperidone | Aziende Chimiche Riunite Angelini Francesco S.p.A | Schizophrenia | 10/22 | 10/22 | | |
NCT04432688: The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients |
|
|
| Completed | N/A | 3192 | RoW | Lurasidone HCl, Latuda® | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 03/23 | 06/23 | | |
NCT06328140: Sleep Quality, Cognitive Performance, and Computerized Cognitive Training |
|
|
| Not yet recruiting | N/A | 80 | US | Lurasidone, FDA Approved antidepressant treatment, Any FDA Approved antidepressant | George West Mental Health Foundation d/b/a Skyland Trail, Sumitomo Pharmaceuticals America | Bipolar Disorder, Major Depressive Disorder, Psychosis | 04/26 | 04/26 | | |
ChiCTR2100050628: Effect of different intervention modes and mechanism of brain-gut axis in overweight or obese patients with bipolar disorder at stable stage |
|
|
| Completed | N/A | 120 | | Healthy lifestyle education and therapy; Orlistat capsule 0.12bid and healthy lifestyle education were added.; Stop the original medication, change to lurasidone and healthy lifestyle education treatment; RTMS treatment was added twice a week and healthy lifestyle education. | The First Affiliated Hospital of Zhejiang University Medical College; The First Affiliated Hospital of Zhejiang University Medical College, Matching funds | Bipolar disorder | | | | |
ChiCTR2400086634: Clinical study of lurasidone combined with SSRIs in the treatment of refractory obsessive-compulsive disorder |
|
|
| Not yet recruiting | N/A | 100 | | Lurasidone (40-80 mg) combined with SSRIs was given for 8 weeks; Use SSRIs alone, adjust the dose based on the original drug, or change to another SSRIs, continuous treatment for 8 weeks | Fuzhou Neuropsychiatric Hospital Affiliated to Fujian Medical University; Fuzhou Neuropsychiatric Hospital Affiliated to Fujian Medical University, Funded by Fuzhou key clinical specialty construction project | Obsessive-compulsive disorder | | | | |
| Recruiting | N/A | 10000 | RoW | Escitalopram Oxalate Tablets, Lexapro, Quetiapine Fumarate Tablets, Seroquel, Lurasidone, Latuda | First Affiliated Hospital of Zhejiang University | Major Depressive Disorder, Bipolar Disorder, Mixed, Affective; Disorder, Organic | 12/26 | 12/26 | | |
